About MiRABO
MiRABO Biotechnology is pioneering the future of biologics with intelligent AI — empowering developers to create safer, smarter, and more scalable protein therapeutics.
Two Cities, One Vision
A global innovation network bridging East and West
Transforming biologics development through intelligent AI
Advancing the way protein therapies are discovered, optimized, and delivered
Our Mission
To accelerate and advance biologics development through intelligent AI, bringing safer and more effective therapies to patients faster.
Our Vision
To shape the next era of biologics through intelligent AI.
From Molecule to Market
A seamless pipeline combining AI prediction with experimental validation
AI-Driven Modeling
Advanced machine learning algorithms predict protein structures, optimize molecular designs, and accelerate discovery timelines
Experimental Validation
Laboratory testing confirms computational predictions, refines biological performance, and ensures real-world efficacy
Process Optimization
Bioprocess engineering maximizes yield, purity, and efficiency while maintaining sustainability standards
Scalable Production
Industrial-scale manufacturing delivers protein therapeutics to global markets efficiently
Our Team
Co-founders
Kyoungho Lee
CEO
- PhD in Biotechnology, Osaka University, Japan
- Postdoc in Chemical Engineering, University of Minnesota, USA
- Global EMBA at CEIBS, China
- Career: LG Chem (Korea), Sanofi (France), Canton Biologics (China)
Junghao Wang
VP, Head of Data Science
- PhD in Biochemical Science, National Taiwan University, Taiwan
- Postdoc in Chemical Engineering, University of Minnesota, USA
- Career: BioMap (China), Wuxi Biologics (China)
Jingyu Wang
VP, Head of Synthetic Biology
- PhD in Chemical Engineering, Tianjin University, China
- Postdoc in Chemical Engineering, University of Minnesota, USA
- Career: West Lake University (Research Prof, China), MintBio (China)
Join Our Journey
Explore how we're transforming biotechnology through AI innovation